Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Emerging Therapy

Aquestive Works with FDA to Resolve Hurdles for its New Sublingual Epinephrine Candidate

Hope on the Horizon: Ten Food Allergy Research Breakthroughs in 2025

Very Low-Dose Multi-Nut OIT Promising for Children with Multiple Food Allergies

DBV to Submit FDA Application After Viaskin Peanut Patch Achieves Goals in Phase 3 Trial

Mabylon Begins Human Clinical Trials of New Peanut Allergy Treatment

Phase 3 Trial Data Demonstrates Consistent Safety and Efficacy of AR101...

Aimmune Announces US FDA Advisory Committee Meeting Date for AR101 for...

Study: Peanut OIT Increases Allergic Reactions, Compared with Avoidance or Placebo

Must Hear: Interview with Stanford Immunologist Dr Kari Nadeau – Defeating...

Researchers Develop First Functional Targeted Inhibitors of Peanut Allergens

Must See: 'ViewFinder: Food for Thought – Food Allergies'

European Phase 3 Trial of AR101 Peanut OIT Candidate Meets Primary...

US FDA Accepts BLA Filing of Aimmune Therapeutics’ AR101 for Peanut...

Update on Delivery of Emergency Epinephrine via Sublingual Film

FDA Approves Dupixent® (dupilumab) for Moderate-to-severe Atopic Dermatitis in Adolescents

Your School On Our Map

Put Your School on the Map